The Walter Reed Army Institute of Research is the largest biomedical research facility administered by the U.S. Department of Defense.

During the past decade, WRAIR Clinical Trials Center, conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "WRAIR Clinical Trials Center," #1 sponsor was "U.S. Army Medical Research and Development Command" with 17 trials, followed by "Armata Pharmaceuticals, Inc." with 1 trials sponsored, "Bio-Rad Laboratories" with 1 trials sponsored, "DynPort Vaccine Company LLC, A GDIT Company" with 1 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "WRAIR Clinical Trials Center," #1 collaborator was "Walter Reed Army Institute of Research (WRAIR)" with 9 trials as a collaborator, "GlaxoSmithKline" with 6 trials as a collaborator, "United States Agency for International Development (USAID)" with 4 trials as a collaborator, "The PATH Malaria Vaccine Initiative (MVI)" with 2 trials as a collaborator and "United States Department of Defense" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "WRAIR Clinical Trials Center," are "Malaria" (5 trials), "Escherichia Coli Infection" (2 trials), "Dengue" (1 trials), "Dengue Fever" (1 trials) and "Dengue Virus" (1 trials). Many other conditions were trialed in "WRAIR Clinical Trials Center," in a lesser frequency.

Most popular intervention types in "WRAIR Clinical Trials Center," are "Biological" (20 trials), "Other" (5 trials), "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Modified E. coli heat labile enterotoxin LTR192G" (2 trials), "Recombinant fimbrial adhesin dscCfaE" (2 trials), "1 µg TDENV-PIV with AS01E1 adjuvant" (1 trials), "1 µg TDENV-PIV with AS03B1 adjuvant" (1 trials) and "1 µg TDENV-PIV with Alum adjuvant" (1 trials). Other intervention names were less common.

The vast majority of trials in "WRAIR Clinical Trials Center," are 22 trials for "All" genders.

Currently, there are NaN active trials in "WRAIR Clinical Trials Center,". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in WRAIR Clinical Trials Center,, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in WRAIR Clinical Trials Center,, 19 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".